The Significance of Serum HBV Pregenomic RNA in Patients with Low HBsAg Chronic Hepatitis B Following Peg-Interferon Alfa Therapy

被引:0
|
作者
Wang, Menglan [1 ]
Chen, Youming [1 ]
Lin, Bingliang [1 ]
Xie, Dongying [1 ]
Deng, Hong [1 ]
Lin, Chaoshuang [1 ]
Xie, Qifeng [1 ]
Zhang, Xiaohong [1 ]
Gao, Zhiliang [1 ]
机构
[1] Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
557
引用
收藏
页码:333A / 333A
页数:1
相关论文
共 50 条
  • [21] Low body weight predicts PEG-interferon alfa-2a (PEGASYS) induced neutropenia in chronic hepatitis C patients
    Rotman, Y
    Ben-Ari, Z
    Braun, M
    Cohen, M
    Cohen-Ezra, O
    Manhaim, V
    Tur-Kaspa, R
    [J]. HEPATOLOGY, 2005, 42 (04) : 664A - 665A
  • [22] Peg-interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Shiha, G.
    Abass, B.
    El-Shenawy, H.
    Zalata, K.
    Attia, M.
    Farouk, D.
    [J]. LIVER INTERNATIONAL, 2006, 26 : 79 - 79
  • [23] Effects of Entecavir on Serum Hepatitis B Virus-DNA, Interferon-γ, and Pregenomic RNA in Patients with Chronic Hepatitis B Virus Infection
    Gong, Xuyang
    Chen, Zhitao
    Zhang, Xiaoxia
    Zheng, Yi
    Zhang, Heng
    [J]. HEPATITIS MONTHLY, 2023, 23 (01)
  • [24] Cost-effectiveness of peg-interferon alfa-2a therapy of HBeAg negative chronic hepatitis B in Italy using a personalized approach based on week 12 HBV-DNA and HBsAg stopping rule
    Iannazzo, Sergio
    Coco, Barbara
    Brunetto, Maurizia R.
    Rossetti, Francesca
    Caputo, Antonietta
    Bonino, Ferruccio
    [J]. HEPATOLOGY, 2012, 56 : 633A - 634A
  • [25] Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
    Huang, Yi-Wen
    Chayama, Kazuaki
    Tsuge, Masataka
    Takahashi, Shoichi
    Hatakeyama, Tsuyoshi
    Abe, Hiromi
    Hu, Jui-Ting
    Liu, Chun-Jen
    Lai, Ming-Yang
    Chen, Ding-Shinn
    Yang, Sien-Sing
    Kao, Jia-Horng
    [J]. ANTIVIRAL THERAPY, 2010, 15 (02) : 177 - 184
  • [26] HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study
    Hu, Peng
    Shang, Jia
    Zhang, Wenhong
    Gong, Guozhong
    Li, Yongguo
    Chen, Xinyue
    Jiang, Jianning
    Xie, Qing
    Dou, Xiaoguang
    Sun, Yongtao
    Li, Yufang
    Liu, Yingxia
    Liu, Guozhen
    Mao, Dewen
    Chi, Xiaoling
    Tang, Hong
    Li, Xiaoou
    Xie, Yao
    Chen, Xiaoping
    Jiang, Jiaji
    Zhao, Ping
    Hou, Jinlin
    Gao, Zhiliang
    Fan, Huimin
    Ding, Jiguang
    Zhang, Dazhi
    Ren, Hong
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 6 (01) : 25 - 34
  • [27] Assessment of hepatitis B virus pregenomic RNA in high and low viremic chronic hepatitis B patients
    Elshayeb, Aymen Farid
    Abdrabu, Mohamed Gamal
    Asar, Sara Lotfy
    Abdelaziz, Mohamed Adel
    Abuelkheir, Hossam
    [J]. CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (01) : 85 - 92
  • [28] IMMUNE DRIVERS OF HBsAg LOSS IN HBEAG NEGATIVE CHRONIC HEPATITIS B PATIENTS AFTER STOPPING NUCLEOTIDE ANALOGUE AND ADMINISTRATION OF PEG-INTERFERON
    Islam, Mojahidul
    Kumar, Karan
    Sevak, Jayesh Kumar
    Jindal, Ankur
    Vyas, Ashish Kumar
    Ramakrishna, Gayatri
    Kottilil, Shyam
    Sharma, Manoj K.
    Sarin, Shiv K.
    Trehanpati, Nirupama
    [J]. HEPATOLOGY, 2022, 76 : S265 - S265
  • [29] PEG-Interferon α-2b+ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon alfa or interferon a-2b+ribavirin therapy.
    Sulkowski, M
    Rothstein, K
    Stein, L
    Godofsky, E
    Goodman, R
    Dieterich, D
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A783 - A783
  • [30] Treatment with Peg-interferon alfa-2b in patients affected by acute hepatitis C: A pilot study
    Scotto, G
    Palumbo, E
    Fazio, V
    Cibelli, DC
    Saracino, A
    Angarano, G
    [J]. HEPATOLOGY, 2004, 40 (04) : 331A - 331A